NCT02951949

Brief Summary

One hundred Spanish postmenopausal women accepted to be investigated for cardiovascular risk actors including clinical features, serum biochemical parameters, single nucleotide polymorphisms for estrogen receptor, and imaging parameters, carotid intima-media thickness (91 women) and coronary computed tomography (32 women). Multivariable analysis confirmed that both age and glucose level directly affected IMT. Estrogenic exposure, as measured by the allele associated with lower expression of the ER beta gene, was protective at the sinus and the wall. Findings at the coronary arteries, either moderate or high calcium index (CAC) and/or significant lumen stenosis were sporadic and did not allow for establishing association with any of the variables assessed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2014

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2015

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2015

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

October 23, 2016

Completed
9 days until next milestone

First Posted

Study publicly available on registry

November 1, 2016

Completed
Last Updated

April 7, 2020

Status Verified

April 1, 2020

Enrollment Period

8 months

First QC Date

October 23, 2016

Last Update Submit

April 3, 2020

Conditions

Keywords

atherosclerosis, endogenous estrogens, age

Outcome Measures

Primary Outcomes (1)

  • Carotid intima-media thickness.

    Postmenopausal women attending clinical service for health control were measured carotid intima-media thickness by ultrasound.

    12 weeks

Secondary Outcomes (2)

  • Changes in coronary calcium score.

    12 weeks

  • Changes in coronary lumen stenosis.

    12 weeks

Study Arms (1)

Postmenopausal women

Postmenopausal women attending the outpatient service of a third level hospital for health control.

Eligibility Criteria

Age45 Years - 85 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Postmenopausal women attending a clinical outpatient service in a third-level hospital for health control.

You may qualify if:

  • Postmenopausal women free of previous diagnosis of cardiovascular disease, Caucasian ethnicity, urban origin, medium or medium-low socioeconomic extraction.

You may not qualify if:

  • Previous diagnosis of cardiovascular disease, inability to understand the purpose and conditions of the study..

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Clínico Universitario

Valencia, 46010, Spain

Location

MeSH Terms

Conditions

AtherosclerosisCoronary Stenosis

Condition Hierarchy (Ancestors)

ArteriosclerosisArterial Occlusive DiseasesVascular DiseasesCardiovascular DiseasesCoronary DiseaseMyocardial IschemiaHeart Diseases

Study Officials

  • Antonio Cano, MD

    University of Valencia

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Full Professor Obstetrics and Gynecology

Study Record Dates

First Submitted

October 23, 2016

First Posted

November 1, 2016

Study Start

November 1, 2014

Primary Completion

July 1, 2015

Study Completion

December 1, 2015

Last Updated

April 7, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

There is no plan to make individual participant data (IPD) available to other researchers.

Locations